How To Beat Your Boss On ADHD Medication Pregnancy

How To Beat Your Boss On ADHD Medication Pregnancy

Blog Article

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. Little data exists about how long-term exposure to these medications could affect the fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as impaired hearing or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality studies are required.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication should evaluate the benefits of using it against the potential dangers for the fetus. Physicians don't have the necessary data to give clear guidelines, but they can provide information regarding risks and benefits that help pregnant women make informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy were not at higher risk of fetal malformations, or structural birth defects. Researchers conducted a large, population-based case-control study to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants during the early stages of pregnancy, and those who did not. Clinical geneticists, pediatric cardiologists and other experts reviewed the cases in order to confirm that the classification was accurate and to minimize any bias.

The study conducted by the researchers was not without its limitations. The researchers were unable, in the first place, to separate the effects of the medication from the disorder. This limitation makes it difficult to determine whether the small associations observed in the groups that were exposed result from medication use or confounding by comorbidities. In addition the study did not look at the long-term outcomes of offspring.

The study revealed that babies whose mothers took ADHD medication during pregnancy had a slightly greater risk of being admitted to the neonatal care unit (NICU) as compared to those whose mothers did not take any medication during pregnancy, or had quit taking the medication prior to or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not affected by the stimulant medication used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher likelihood of having to have an emergency caesarean section or having the baby was not scoring well on the Apgar scale (less than 7). These increases appear to be independent of the type of medication used during pregnancy.

The researchers suggest that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefits to both mother and child from continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, where possible, assist them in developing strategies to improve their coping abilities which can reduce the negative impact of her condition on her daily life and relationships.

Medication Interactions

Doctors are increasingly confronted with the dilemma of whether to keep treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are frequently taken without clear and authoritative evidence. Instead, doctors must weigh their own knowledge, the experience of other doctors and the research that has been conducted on the subject.

The issue of risk to infants is difficult to determine. The research on this subject is based on observation rather than controlled studies, and the results are in conflict. The majority of studies restrict their analysis to live births, which may underestimate the teratogenic impact leading to terminations or abortions of pregnancy. The study that is discussed in the journal club addresses these shortcomings by analyzing both data on live and deceased births.

Conclusion Some studies have found an association between ADHD medications and certain birth defects, other studies have not established a link. The majority of studies show that there is a neutral, or somewhat negative, effect. As a result, a careful risk/benefit analysis must be conducted in every situation.

It can be difficult, if not impossible for women suffering from ADHD to stop taking their medication. In fact, in a recent article in Archives read more of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of isolation and family conflict for these patients. Furthermore, a loss of medication may affect the ability to complete job-related tasks and drive safely, which are important aspects of a normal life for a lot of people with ADHD.

She suggests that women who aren't sure whether to continue taking medication or discontinue it due to pregnancy educate family members, coworkers, and acquaintances about the condition, its effects on daily functioning, and the advantages of staying on the current treatment. It can also help a woman feel confident about her decision. It is important to remember that some medications can pass through the placenta so if a woman decides to discontinue her ADHD medication during pregnancy and breastfeeding, she must be aware that the effects of the drug can be transferred to the infant.

Risk of Birth Defects

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns over the impact that these drugs could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this subject. Using two massive data sets, researchers were able to analyze more than 4.3 million pregnancies and determine whether the use of stimulant medications increased the risk of birth defects. Researchers found that while the risk overall is low, the first trimester ADHD medication exposure was associated with slightly higher risk of specific heart defects like ventriculoseptal defect.

The authors of the study found no association between the use of early medications and other congenital anomalies, like facial clefting, or club foot. The findings are in line with previous studies that have shown the presence of a small, but significant increase in the risk of developing cardiac malformations among women who started taking ADHD medications prior to the time of the birth of their child. This risk increased during the latter stages of pregnancy, when a lot of women stopped taking their medication.

Women who were taking ADHD medication during the first trimester were more likely to require a caesarean delivery and also have a low Apgar after delivery and have a baby that needed breathing assistance when they were born. However, the authors of the study were unable to eliminate bias due to selection by limiting the study to women who didn't have other medical issues that could have contributed to the findings.

The researchers hope that their research will serve to inform the clinical decisions of doctors who treat pregnant women. They advise that while a discussion of the risks and benefits is crucial but the decision to stop or continue treatment should be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also advise that even though stopping the medication is an alternative, it is not an option that is recommended due to the high prevalence of depression and other mental health problems among women who are pregnant or postpartum. Further, the research suggests that women who decide to stop their medications are more likely to experience difficulties getting used to life without them following the birth of their baby.

Nursing

The responsibilities that come with being a new mother can be overwhelming. Women suffering from ADHD may face a lot of challenges when they have to manage their symptoms, go to doctor appointments, prepare for the birth of a baby and adjust to new routines. Therefore, many women choose to continue taking their ADHD medication throughout the pregnancy.

The risk for breastfeeding infant is not too high since the majority of stimulant medication is absorbed through breast milk at low levels. However, the rate of exposure to medications by the infant can differ based on dosage, how often it is taken and at what time it is administered. In addition, various medications are introduced into the baby's system through the gastrointestinal tract, or through breast milk. The effect on a newborn's health is not fully understood.

Some doctors may stop taking stimulant medication during a woman’s pregnancy due to the absence of research. This is a difficult choice for the patient, who must weigh the benefit of continuing her medication against the possible dangers to the foetus. In the meantime, until more information is available, GPs should ask all pregnant patients about their history of ADHD and if they are planning or taking to take medication during the perinatal time.

Numerous studies have proven that women can continue to take their ADHD medication safely while breastfeeding and during pregnancy. As a result, more and more patients opt to do this, and after consulting with their doctor, they have found that the benefits of maintaining their current medication exceed any risk.

It is crucial for women suffering from ADHD who are contemplating breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication with their prescriber as well as the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation is also necessary to help pregnant women with ADHD be aware of the symptoms and the underlying disorder. They should also learn about treatment options and strengthen coping mechanisms. This should include an approach that is multidisciplinary, including the GP doctors, obstetricians and psychiatrists. Pregnancy counseling should include a discussion of a treatment plan for the mother and child, as well as monitoring for signs of deterioration and, if necessary, adjustments to the medication regime.